Studies have suggested that the combined detection of serum IL-6 and hsa-miR-126-5p may help to predict the severity of AP early and that IL-6 acts as an independent risk factor in predicting the prognosis of AP patients (Li et al. 2020; Robb et al. 2018). Here, IL6 is linked to alkaline phosphatase measurement.